Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues
- PMID: 3621111
- DOI: 10.1002/1097-0142(19870915)60:6<1275::aid-cncr2820600619>3.0.co;2-i
Polyamine biosynthetic activity in normal and neoplastic human colorectal tissues
Abstract
Polyamine biosynthetic activity was assessed in various colorectal tissue samples consisting of noninvolved mucosa, benign adenomatous polyps and adenocarcinomas taken at surgery from a total of 40 patients. Ornithine decarboxylase (ODC) displayed a gradient of enzyme activity (i.e., adenocarcinoma greater than polyps greater than mucosa) which seemed to correlate positively with the neoplastic status of the tissue. In 10 of the patients, samples were obtained for all three tissue types. Five of these exhibited a clear repetition of the trends in enzyme activity seen with the mixed patient tissue sampling whereas the remainder differed by having the highest ODC activity in the polyps. In nine of the ten cases, ODC activity was substantially lower in the mucosa than in either of the neoplastic lesions. Trends in enzyme activity were the same for tissues obtained from either the colon or rectum. The ODC activity in adenocarcinomas could not be correlated with histologic differentiation, stage or site of the disease, however, in samples from female patients (all postmenopausal) the activity was elevated over normal mucosa to a greater extent (ten-fold) than in male patients (seven-fold). S-adenosylmethionine decarboxylase activity was assessed in 27 of the 40 patients and found to follow the same distribution as ODC; however, the mean value differences +/- SEM between tissues were less distinct. In general, tissue polyamine pool analysis of these same specimens reflected the levels of ornithine and S-adenosylmethionine decarboxylase activities. Overall, the data reveal an increase in polyamine biosynthetic activity in colorectal neoplasms, relative to surrounding mucosa, which may correlate with (1) progression of the neoplastic process, (2) the proportion of proliferating cells, (3) the rate of cell proliferation, or (4) a combination of two or all of these possibilities.
Similar articles
-
High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia.Ann Surg. 1986 Jul;204(1):89-93. doi: 10.1097/00000658-198607000-00013. Ann Surg. 1986. PMID: 3729588 Free PMC article.
-
Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa.Dis Colon Rectum. 1993 Jul;36(7):662-7. doi: 10.1007/BF02238593. Dis Colon Rectum. 1993. PMID: 8348850
-
Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):369-74. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8348060
-
Ornithine decarboxylase as a marker for colorectal polyps and cancer.Prog Clin Biol Res. 1988;279:227-39. Prog Clin Biol Res. 1988. PMID: 3054922 Review.
-
Polyamines in intestinal and pancreatic adaptation.Gut. 1987;28 Suppl(Suppl):95-101. doi: 10.1136/gut.28.suppl.95. Gut. 1987. PMID: 3121457 Free PMC article. Review.
Cited by
-
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.J Biol Chem. 2006 Jul 14;281(28):19055-63. doi: 10.1074/jbc.M600910200. Epub 2006 May 4. J Biol Chem. 2006. PMID: 16679312 Free PMC article.
-
EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration.J Cell Sci. 2023 Jun 15;136(12):jcs260427. doi: 10.1242/jcs.260427. Epub 2023 Jun 16. J Cell Sci. 2023. PMID: 37325974 Free PMC article.
-
Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.Breast Cancer Res Treat. 2012 Nov;136(1):57-66. doi: 10.1007/s10549-012-2235-x. Epub 2012 Sep 14. Breast Cancer Res Treat. 2012. PMID: 22976807 Free PMC article.
-
Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia.Dig Dis Sci. 1992 Nov;37(11):1718-24. doi: 10.1007/BF01299865. Dig Dis Sci. 1992. PMID: 1425072
-
Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.Cancer Chemother Pharmacol. 2011 Feb;67(2):401-14. doi: 10.1007/s00280-010-1334-9. Epub 2010 May 5. Cancer Chemother Pharmacol. 2011. PMID: 20443003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials